Author

S. Tominaga

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

A. E. Carpenter· 1 shared H. Kitamura· 1 shared H. Segawa· 1 shared J. Jin· 1 shared J. Watanabe· 1 shared K. Ikeo· 1 shared K. Kadoya· 1 shared K. Nagahama· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. E. Carpenter

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintApr 19, 2022

Predicting gene expression from cell morphology in human induced pluripotent stem cells

T. Wakui, M. Negishi, Y. Murakami…·H. Segawa

The paper builds a model to predict gene expression from cell morphology in hiPSCs and identifies two genes well-predicted by morphology.

DOI 10.1101/2022.04.19.488786

𝕏 PostBluesky

Cell BiologybioRxivAug 27, 2018

Pirfenidone attenuates lung fibrotic fibroblast-mediated fibrotic responses to transforming growth factor-β1

J. Jin, S. Togo, K. Kadoya…·K. Takahashi

This study shows pirfenidone reduces fibrotic responses in lung fibroblasts by inhibiting CTHRC1, suggesting it as a potential therapeutic target for lung fibrosis.

DOI 10.1186/s12931-019-1093-z

humanproteomics

𝕏 PostBluesky